Saturday, May 23, 2015 Last update: Yesterday, 10:03 PM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

AtheroNova Inc.

News articles for AtheroNova Inc.:

Tuesday, March 3, 2015

  • AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection
    IRVINE, Calif., March 3, 2015 /PRNewswire/ -- AtheroNova Inc. (OTCQB: AHRO) today announced that the Company and its subsidiary, AtheroNova Operations, Inc., filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court, Central District of California, Santa Ana division (the "Bankruptcy ... read more

Thursday, February 19, 2015

  • AtheroNova Receives Additional Notices of Debt Acceleration
    IRVINE, Calif., Feb. 19, 2015 /PRNewswire/ -- AtheroNova Inc. (OTCQB: AHRO) today announced that after its filing of a Current Report on Form 8-K disclosing that on February 12, 2015 it received a notice of acceleration from Europa International, Inc., the holder of a 2.5% Senior Secured ... read more

Friday, February 13, 2015

  • AtheroNova Receives Notice of Debt Acceleration
    IRVINE, Calif., Feb. 13, 2015 /PRNewswire/ -- AtheroNova Inc. (OTCQB: AHRO) today announced that it filed a Current Report on Form 8-K disclosing that on February 12, 2015 it received a notice of acceleration from Europa International, Inc., the holder of a 2.5% Senior Secured Convertible Note ... read more
  • AtheroNova Receives Notice of Issuance of Its 3rd US Patent
    IRVINE, Calif., Feb. 13, 2015 /PRNewswire/ -- AtheroNova Inc. (OTCQB: AHRO) today announced that it has received a Notice of Issuance of Patent No. 8952067 titled "Subcutaneous Fat Reduction" by the United States Patent and Trade Office with an expiration date of June 20, 2032. About AtheroNovaAtheroNova Inc. ... read more

Tuesday, January 29, 2013

  • AtheroNova Launches New Website
    IRVINE, CA--(Marketwire - January 29, 2013) - AtheroNova Inc. (OTCQB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced the launch ... read more

Wednesday, August 24, 2011

Monday, June 13, 2011

Monday, May 16, 2011

Tuesday, May 3, 2011

Monday, April 11, 2011

Tuesday, March 1, 2011

Tuesday, February 22, 2011

Monday, January 10, 2011

Wednesday, November 17, 2010

Tuesday, November 9, 2010

Tuesday, September 21, 2010

  • AtheroNova Inc. Announces Results of Initial Pre-Clinical Study
    IRVINE, CA -- (Marketwire) -- 09/21/10 -- AtheroNova Inc. (OTCBB: AHRO) ("AtheroNova"), a biotech company focused on the research and development of compounds to regress atherosclerotic plaque, announced results of the Company's initial animal study conducted at a major university demonstrating the study group having a 95% less ... read more

Wednesday, September 15, 2010

Wednesday, July 28, 2010

Monday, June 28, 2010